Alejandro Moreno

@Alejandro_AGMo

Médico 🎓 Hincha de los mas grandes: Club Social Rugby y River Plate

La Rioja, Argentina

Joined January 2011

604 Following

270 Followers

800 Posts

Alejandro Moreno @Alejandro_AGMo

about 1 year ago

@CorreaSadouet @clinicasac @apsicosocialSAC Ahí estaremos Dra! 🙌🏽

Alejandro_AGMo retweeted

Matias Rodriguez G 🇦🇷 ⭐⭐⭐ @matiasrg

over 1 year ago

Un placer trabajar con este grupo ❤️ El equipo de cardiología intervencionista a pleno 🎈➰ #Otamendi #laslomas

416

Alejandro_AGMo retweeted

Davide Capodanno

@DFCapodanno

over 2 years ago

Targeting residual inflammatory risk across the full spectrum of atherosclerotic disease is the next frontier for atherosclerosis treatment and prevention. In patients with residual inflammatory risk, based on guidelines, low-dose colchicine can be added to statin therapy as well as to background therapies that might include multiple other adjunctive lipid lowering agents. Trials are in planning or underway evaluating interleukin-6 inhibition in the settings of chronic kidney disease, heart failure with preserved ejection fraction, acute coronary ischemia, and hemodialysis. The ARTEMIS trial is about to start. It is a phase 3, event-driven trial of approximately 10000 patients with recent type 1 acute myocardial infarction, who will be randomized to the anti-IL-6 monoclonal antibody ziltivekimab or placebo, on top of standard of care. The primary endpoint is a composite of cardiovascular death, myocardial infarction, or stroke.

$DFCapodanno's tweet photo. Targeting residual inflammatory risk across the full spectrum of atherosclerotic disease is the next frontier for atherosclerosis treatment and prevention. In patients with residual inflammatory risk, based on guidelines, low-dose colchicine can be added to statin therapy as well as to background therapies that might include multiple other adjunctive lipid lowering agents. Trials are in planning or underway evaluating interleukin-6 inhibition in the settings of chronic kidney disease, heart failure with preserved ejection fraction, acute coronary ischemia, and hemodialysis. The ARTEMIS trial is about to start. It is a phase 3, event-driven trial of approximately 10000 patients with recent type 1 acute myocardial infarction, who will be randomized to the anti-IL-6 monoclonal antibody ziltivekimab or placebo, on top of standard of care. The primary endpoint is a composite of cardiovascular death, myocardial infarction, or stroke.$

107

11K

Alejandro_AGMo retweeted

Resistencia Nacional

@ResistenciaNac_

over 2 years ago

Si Cavallo dice que Milei es bueno, entonces hay que votar a Massa.

234K

Who to follow

Pablo Romero

@Romero_Pablo19

Lic. en administración. #CABJ y @socialrugby_ Say no more...

Alejandro Moreno @Alejandro_AGMo

almost 3 years ago

@napoarce @medinternajg https://t.co/z18GtKZD6u

Alejandro_AGMo retweeted

Bruno Altieri

@altieribruno

almost 3 years ago

Hace 31 años, un equipo único en la historia del básquetbol ganaba el oro en Barcelona 1992. Hablamos, por supuesto, del irreproducible y surrealista Dream Team. Michael Jordan, Magic Johnson y Larry Bird juntos. Extraterrestres contra seres humanos. El mito de la NBA que desciende al planeta tierra. El sueño de David Stern en marcha: viajemos, entonces, con un ticket dorado hacia el pasado. Abro hilo.

altieribruno's tweet photo. Hace 31 años, un equipo único en la historia del básquetbol ganaba el oro en Barcelona 1992. Hablamos, por supuesto, del irreproducible y surrealista Dream Team. Michael Jordan, Magic Johnson y Larry Bird juntos. Extraterrestres contra seres humanos. El mito de la NBA que desciende al planeta tierra. El sueño de David Stern en marcha: viajemos, entonces, con un ticket dorado hacia el pasado. Abro hilo.

366

34K

Alejandro_AGMo retweeted

Sudanalytics

@sudanalytics_

over 3 years ago

5EXO FERNÁNDEZ. 🚬

146

57K

256

Alejandro_AGMo retweeted

Paris Saint-Germain

@PSG_espanol

over 3 years ago

👕 ¡SORTEAMOS LA CAMISETA FIRMADA POR NUESTRO CAMPEÓN DEL MUNDO! 🔥 ¿Cómo participar? 1. Seguir a @PSG_espanol 2. Dar RT a este tuit 3. ¡Mucha suerte! ¡VAMOS, PARIS! ❤️💙